CRYOPORT, INC. Finance Lease, Weighted Average Discount Rate, Percent
CRYOPORT, INC. (CYRX) had Finance Lease, Weighted Average Discount Rate, Percent of 7.60% as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-06
- 2026-06-30: Finance Lease, Weighted Average Discount Rate, Percent 7.60%.
- 2026-03-31: Finance Lease, Weighted Average Discount Rate, Percent 8.40%.
- 2025-12-31: Finance Lease, Weighted Average Discount Rate, Percent 8.40%.
- 2025-09-30: Finance Lease, Weighted Average Discount Rate, Percent 8.40%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 7.60% 10-Q · filed 2026-08-06 |
| 2026-03-31 | 8.40% 10-Q · filed 2026-05-05 |
| 2025-12-31 | 8.40% 10-Q · filed 2026-08-06 |
| 2025-09-30 | 8.40% 10-Q · filed 2025-11-06 |
| 2025-06-30 | 8.00% 10-Q · filed 2025-08-12 |
| 2025-03-31 | 3.30% 10-Q · filed 2025-05-08 |
| 2024-12-31 | 8.30% 10-K · filed 2026-03-05 |
| 2024-09-30 | 8.30% 10-Q · filed 2024-11-07 |
| 2024-06-30 | 8.60% 10-Q · filed 2024-08-08 |
| 2024-03-31 | 7.80% 10-Q · filed 2024-05-08 |
| 2023-12-31 | 8.40% 10-K · filed 2025-03-07 |
| 2023-09-30 | 8.50% 10-Q · filed 2023-11-09 |
| 2023-06-30 | 8.40% 10-Q · filed 2024-08-08 |
| 2023-03-31 | 7.90% 10-Q · filed 2023-05-04 |
| 2022-12-31 | 7.80% 10-K · filed 2024-03-13 |
| 2022-09-30 | 7.80% 10-Q · filed 2023-11-09 |
| 2021-12-31 | 5.30% 10-K · filed 2023-02-28 |
| 2021-09-30 | 5.30% 10-Q · filed 2021-11-04 |
| 2021-06-30 | 5.30% 10-Q · filed 2021-08-06 |
| 2021-03-31 | 5.30% 10-Q · filed 2021-05-06 |
| 2020-12-31 | 5.40% 10-K · filed 2022-02-28 |
| 2020-09-30 | 5.40% 10-Q · filed 2020-11-06 |
| 2020-06-30 | 5.40% 10-Q · filed 2020-08-10 |
| 2020-03-31 | 5.40% 10-Q · filed 2020-05-08 |
| 2019-12-31 | 6.00% 10-K · filed 2020-03-10 |
| 2019-09-30 | 6.00% 10-Q · filed 2019-11-12 |
| 2019-06-30 | 6.00% 10-Q · filed 2019-08-09 |
| 2019-03-31 | 6.00% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |